| human | Q5 |
| P2671 | Google Knowledge Graph ID | /g/11fhvxjh6b |
| P244 | Library of Congress authority ID | n00122938 |
| P214 | VIAF ID | 11085918 |
| P10832 | WorldCat Entities ID | E39PBJbxBpKgwQf6JdwrYr9hpP |
| P166 | award received | Prince Mahidol Award | Q2110577 |
| P108 | employer | University of California, Los Angeles | Q174710 |
| P734 | family name | Clemens | Q27133250 |
| Clemens | Q27133250 | ||
| Clemens | Q27133250 | ||
| P101 | field of work | cholera | Q12090 |
| P735 | given name | John | Q4925477 |
| John | Q4925477 | ||
| P21 | sex or gender | male | Q6581097 |
| Q53311743 | 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. |
| Q89779855 | A Community-Based Intervention for Managing Hypertension in Rural South Asia |
| Q36635661 | A Multicountry Molecular Analysis of Salmonella enterica Serovar Typhi With Reduced Susceptibility to Ciprofloxacin in Sub-Saharan Africa |
| Q39961128 | A cluster-randomized effectiveness trial of Vi typhoid vaccine in India. |
| Q80840043 | A community-based cluster survey on preferences for treatment of diarrhoea and dysentery in Zhengding county, Hebei province, China |
| Q39972060 | A comparison of disease caused by Shigella and Campylobacter species: 24 months community based surveillance in 4 slums of Karachi, Pakistan |
| Q46908354 | A cost function analysis of shigellosis in Thailand |
| Q39703429 | A cost-benefit analysis of typhoid fever immunization programmes in an Indian urban slum community. |
| Q27473264 | A hospital-based surveillance for Japanese encephalitis in Bali, Indonesia |
| Q24811133 | A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; expanding the use of Vi polysaccharide vaccine in southeast China: a cluster-randomized trial |
| Q35627409 | A model immunization programme to control Japanese encephalitis in Viet Nam |
| Q33229681 | A multi-country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and design. |
| Q28767862 | A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology |
| Q37675484 | A national cholera vaccine stockpile--a new humanitarian and diplomatic resource |
| Q90128017 | A randomized Phase I/II study to evaluate safety and reactogenicity of a heat-stable rotavirus vaccine in healthy adults followed by evaluation of the safety, reactogenicity, and immunogenicity in infants |
| Q21144301 | A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India |
| Q33330938 | A study of typhoid fever in five Asian countries: disease burden and implications for controls |
| Q43039360 | Accelerating the development and introduction of a dengue vaccine for poor children, 5-8 December 2001, Ho Chi Minh City, VietNam |
| Q33327527 | Adults' perceived prevalence of enteric fever predicts laboratory-validated incidence of typhoid fever in children |
| Q30410505 | An overview of cholera vaccines and their public health implications |
| Q33301096 | Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones |
| Q39371924 | Antimicrobial susceptibility trends in Campylobacter jejuni and Campylobacter coli isolated from a rural Egyptian pediatric population with diarrhea |
| Q46719657 | Antimicrobial treatment for cholera |
| Q40507378 | Application of cluster randomization method on typhoid Vi vaccine trails |
| Q92652784 | Assessing Vaccine Herd Protection by Killed Whole-Cell Oral Cholera Vaccines Using Different Study Designs |
| Q40545451 | Assessing different measures of population-level vaccine protection using a case-control study. |
| Q34550819 | Assessing effects of cholera vaccination in the presence of interference |
| Q64119992 | Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infection Among Bangladeshi Children: A Protocol for a Phase IIIb Trial |
| Q33910444 | Assessment and comparative analysis of a rapid diagnostic test (Tubex®) for the diagnosis of typhoid fever among hospitalized children in rural Tanzania |
| Q39636287 | Association between Helicobacter pylori infection and increased risk of typhoid fever |
| Q92264656 | Augmented immune responses to a booster dose of oral cholera vaccine in Bangladeshi children less than 5 years of age: Revaccination after an interval of over three years of primary vaccination with a single dose of vaccine |
| Q36133468 | Bloodstream Infections and Frequency of Pretreatment Associated With Age and Hospitalization Status in Sub-Saharan Africa |
| Q24799233 | Breastfeeding practices in a cohort of inner-city women: the role of contraindications |
| Q112638071 | Burden of enteric fever at three urban sites in Africa and Asia: a multicentre population-based study |
| Q89999663 | Can Cholera "Hotspots" be Converted to Cholera "Coldspots" in Cholera Endemic Countries? The Matlab, Bangladesh Experience |
| Q95848107 | Case Report: Salmonella Enterica Serovar Paratyphi B Infection in a Febrile Ill Child during Enhanced Passive Surveillance in an Urban Slum in Mirpur, Dhaka |
| Q30373379 | Characteristics of a pandemic clone of O3 : K6 and O4 : K68 Vibrio parahaemolyticus isolated in Beira, Mozambique. |
| Q57464761 | Cholera Control and Prevention in Bangladesh: An Evaluation of the Situation and Solutions |
| Q97415491 | Cholera and Pancreatic Cholera: Is VIP the Common Pathophysiologic Factor? |
| Q47391653 | Cholera in Yemen - An Old Foe Rearing Its Ugly Head |
| Q37191671 | Cholera outbreaks caused by an altered Vibrio cholerae O1 El Tor biotype strain producing classical cholera toxin B in Vietnam in 2007 to 2008. |
| Q37138956 | Cholera vaccines for the developing world. |
| Q30235247 | Cholera. |
| Q48066726 | Classical RS1 and environmental RS1 elements in Vibrio cholerae O1 El Tor strains harbouring a tandem repeat of CTX prophage: revisiting Mozambique in 2005. |
| Q44302592 | Classification of hybrid and altered Vibrio cholerae strains by CTX prophage and RS1 element structure. |
| Q34532346 | Clinical and epidemiological features of typhoid fever in Pemba, Zanzibar: assessment of the performance of the WHO case definitions |
| Q30332251 | Clinical, epidemiological, and socioeconomic analysis of an outbreak of Vibrio parahaemolyticus in Khanh Hoa Province, Vietnam. |
| Q34424182 | Clinical, epidemiological, and spatial characteristics of Vibrio parahaemolyticus diarrhea and cholera in the urban slums of Kolkata, India |
| Q34238915 | Community participation in two vaccination trials in slums of Kolkata, India: a multi-level analysis. |
| Q80594569 | Comparison of cost-of-illness with willingness-to-pay estimates to avoid shigellosis: evidence from China |
| Q33302557 | Comparisons of predictors for typhoid and paratyphoid fever in Kolkata, India |
| Q58897741 | Consecutive outbreaks of Vibrio cholerae O139 and V. cholerae O1 cholera in a fishing village near Karachi, Pakistan |
| Q51732904 | Considerations around the introduction of a cholera vaccine in Bangladesh. |
| Q21144664 | Controlling endemic cholera with oral vaccines |
| Q45790832 | Correction: Clinical and Epidemiological Features of Typhoid Fever in Pemba, Zanzibar: Assessment of the Performance of the WHO Case Definitions. |
| Q46030208 | Correction: Risk Map of Cholera Infection for Vaccine Deployment: The Eastern Kolkata Case. |
| Q55494600 | Correction: Risk Map of Cholera Infection for Vaccine Deployment: The Eastern Kolkata Case. |
| Q45925153 | Correction: The burden of diarrhoea, shigellosis, and cholera in North Jakarta, Indonesia: findings from 24 months surveillance. |
| Q58897694 | Corrigendum to “Impact of Vi vaccination on spatial patterns of typhoid fever in the slums of Kolkata, India” [Vaccine 29 (2011) 9051–9056] |
| Q33790370 | Cost of illness due to typhoid fever in five Asian countries |
| Q33349291 | Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia |
| Q33510195 | Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis |
| Q36947792 | Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China |
| Q39703422 | Costs of illness due to typhoid fever in an Indian urban slum community: implications for vaccination policy. |
| Q40145989 | Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh |
| Q79822703 | Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam |
| Q28742561 | Decreasing incidence of severe malaria and community-acquired bacteraemia among hospitalized children in Muheza, north-eastern Tanzania, 2006-2010 |
| Q38408278 | Desirability for a typhoid fever vaccine among rural residents, Pemba Island, Tanzania |
| Q33715816 | Detection of Shigella by a PCR assay targeting the ipaH gene suggests increased prevalence of shigellosis in Nha Trang, Vietnam |
| Q82728298 | Developing the next generation of vaccinologists |
| Q38948659 | Development of pathogenicity-driven definitions of outcomes for a field trial of a killed oral vaccine against enterotoxigenic Escherichia coli in Egypt: application of an evidence-based method |
| Q35677463 | Diarrheal Illness and Healthcare Seeking Behavior among a Population at High Risk for Diarrhea in Dhaka, Bangladesh |
| Q31119501 | Diarrhoea episodes and treatment-seeking behaviour in a slum area of North Jakarta, Indonesia. |
| Q40498833 | Differences in perception of dysentery and enteric fever and willingness to receive vaccines among rural residents in China |
| Q61881536 | Differences in perception of dysentery and enteric fever and willingness to receive vaccines among rural residents in China |
| Q92801246 | Doubly Robust Estimation in Observational Studies with Partial Interference |
| Q98160160 | Early Insights From Clinical Trials of Typhoid Conjugate Vaccine |
| Q51183481 | Ecological aspects in vaccine trials. |
| Q40043301 | Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan |
| Q40061329 | Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study |
| Q39708620 | Effectiveness of mass oral cholera vaccination in Beira, Mozambique |
| Q44235991 | Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial |
| Q57937611 | Efficacy calculation in randomized trials: global or local measures? |
| Q40371673 | Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh |
| Q49796198 | Efficacy of a bivalent killed whole-cell cholera vaccine over five years: a re-analysis of a cluster-randomized trial |
| Q40501294 | Efficacy of a locally produced, Chinese Vi polysaccharide typhoid fever vaccine during six years of follow-up. |
| Q34058784 | Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial |
| Q52650640 | Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial. |
| Q30341363 | Emergence and serovar transition of Vibrio parahaemolyticus pandemic strains isolated during a diarrhea outbreak in Vietnam between 1997 and 1999. |
| Q46749071 | Emergence of highly fluoroquinolone-resistant Salmonella enterica serovar Typhi in a community-based fever surveillance from Kolkata, India |
| Q57929912 | Emergency deployment of oral cholera vaccine for the Rohingya in Bangladesh |
| Q37061435 | Enhanced disease surveillance through private health care sector cooperation in Karachi, Pakistan: experience from a vaccine trial |
| Q35044847 | Enteric fever burden in North Jakarta, Indonesia: a prospective, community-based study |
| Q38858613 | Epidemiology of Shigella-associated diarrhea in rural Egyptian children. |
| Q92506600 | Epidemiology of cholera |
| Q40071658 | Epidemiology, clinical presentation, and patterns of drug resistance of Salmonella Typhi in Karachi, Pakistan |
| Q39778984 | Estimates of intraclass correlation coefficient and design effect for surveys and cluster randomized trials on injection use in Pakistan and developing countries |
| Q37061211 | Estimating the burden of shigellosis in Thailand: 36-month population-based surveillance study |
| Q34083583 | Evaluating investments in typhoid vaccines in two slums in Kolkata, India |
| Q34290950 | Evaluation of a rapid dipstick (Crystal VC) for the diagnosis of cholera in Zanzibar and a comparison with previous studies |
| Q31057455 | Evaluation of new-generation serologic tests for the diagnosis of typhoid fever: data from a community-based surveillance in Calcutta, India |
| Q30984758 | Evaluation of the Widal tube agglutination test for the diagnosis of typhoid fever among children admitted to a rural hdospital in Tanzania and a comparison with previous studies |
| Q40438972 | Evaluation on the safety of a group A + C meningococcal polysaccharide vaccine |
| Q30406370 | Evidence for several waves of global transmission in the seventh cholera pandemic |
| Q96583950 | Factors associated with occurrence of salmonellosis among children living in Mukuru slum, an urban informal settlement in Kenya |
| Q38460606 | Factors associated with reported diarrhoea episodes and treatment-seeking in an urban slum of Kolkata, India |
| Q40631042 | Faecal contamination of commuters' hands in main vehicle stations in Dhaka city, Bangladesh. |
| Q40295575 | Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial |
| Q39736985 | Feasibility of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique |
| Q25256629 | Field evaluation of a rapid immunochromatographic dipstick test for the diagnosis of cholera in a high-risk population |
| Q35170821 | Flexibility of oral cholera vaccine dosing-a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone. |
| Q40260422 | Formative research and development of an evidence-based communication strategy: the introduction of Vi typhoid fever vaccine among school-aged children in Karachi, Pakistan |
| Q39868883 | Frequency of isolation of various subtypes and antimicrobial resistance of Shigella from urban slums of Karachi, Pakistan |
| Q24794127 | Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt |
| Q57937173 | Genetic diversity of El Tor strains of Vibrio cholerae O1 with hybrid traits isolated from Bangladesh and Mozambique |
| Q89664211 | Genome Dynamics of Vibrio cholerae Isolates Linked to Seasonal Outbreaks of Cholera in Dhaka, Bangladesh |
| Q30360447 | Genomic analysis of the Mozambique strain of Vibrio cholerae O1 reveals the origin of El Tor strains carrying classical CTX prophage. |
| Q51693261 | Geographic analysis of shigellosis in Vietnam. |
| Q40459180 | Geographic analysis of vaccine uptake in a cluster-randomized controlled trial in Hue, Vietnam. |
| Q92781216 | HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh |
| Q82767283 | Haemophilus influenzae type B meningitis among children in Hanoi, Vietnam: epidemiologic patterns and estimates of H. Influenzae type B disease burden |
| Q91729311 | Health Concerns in Urban Slums: A Glimpse of Things to Come? |
| Q40402812 | Health care preferences for children with typhoid fever in two slum communities in Karachi, Pakistan |
| Q44502813 | Healthcare use for diarrhoea and dysentery in actual and hypothetical cases, Nha Trang, Viet Nam. |
| Q44716334 | Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis |
| Q40088781 | Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India. |
| Q64941637 | Herd protection of unvaccinated adults by oral cholera vaccines in rural Bangladesh. |
| Q80349885 | Hib vaccines for all the world's children? |
| Q36892188 | High Disease Burden of Diarrhea Due to Enterotoxigenic Escherichia coli among Rural Egyptian Infants and Young Children |
| Q98193567 | High relatedness of invasive multi-drug resistant non-typhoidal Salmonella genotypes among patients and asymptomatic carriers in endemic informal settlements in Kenya |
| Q34150129 | High-resolution genotyping of the endemic Salmonella Typhi population during a Vi (typhoid) vaccination trial in Kolkata. |
| Q91008222 | How Can the Typhoid Fever Surveillance in Africa and the Severe Typhoid Fever in Africa Programs Contribute to the Introduction of Typhoid Conjugate Vaccines? |
| Q84569360 | Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial |
| Q33601836 | Immune responses to Vi capsular polysaccharide typhoid vaccine in children 2 to 16 years old in Karachi, Pakistan, and Kolkata, India |
| Q36476975 | Immunization against Japanese encephalitis in China: a policy analysis |
| Q90356433 | Immunogenicity of a killed bivalent whole cell oral cholera vaccine in forcibly displaced Myanmar nationals in Cox's Bazar, Bangladesh |
| Q40311354 | Impact of Vi vaccination on spatial patterns of typhoid fever in the slums of Kolkata, India |
| Q47810215 | Impact of adding hand-washing and water disinfection promotion to oral cholera vaccination on diarrhoea-associated hospitalization in Dhaka, Bangladesh: evidence from a cluster randomized control trial |
| Q92951266 | Impact of vaccination on the risk factors for acute rotavirus diarrhea: An analysis of the data of a cluster randomized trial conducted in a rural area of Bangladesh |
| Q33265284 | Implementation of good clinical practice guidelines in vaccine trials in developing countries |
| Q59326280 | Incidence of Diarrhea Caused by Rotavirus Infections in Rural Zhengding, China: Prospective, Population‐Based Surveillance |
| Q37651735 | Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study |
| Q39639130 | Infant-parent bed sharing in an inner-city population |
| Q30404677 | Influenza and bacterial pathogen coinfections in the 20th century. |
| Q39433548 | Introductory evaluation of an oral, killed whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Egyptian infants |
| Q30978129 | Invasive salmonellosis among children admitted to a rural Tanzanian hospital and a comparison with previous studies |
| Q44758797 | Is HIV infection associated with an increased risk for cholera? Findings from a case-control study in Mozambique |
| Q35744920 | Is a Cholera Outbreak Preventable in Post-earthquake Nepal? |
| Q33263723 | Isolation of Salmonella enterica subspecies enterica serovar Paratyphi B dT+, or Salmonella Java, from Indonesia and alteration of the d-tartrate fermentation phenotype by disrupting the ORF STM 3356. |
| Q34804222 | Lessons and implications from a mass immunization campaign in squatter settlements of Karachi, Pakistan: an experience from a cluster-randomized double-blinded vaccine trial [NCT00125047]. |
| Q51899664 | Long-term disability from acute childhood Japanese encephalitis in Shanghai, China. |
| Q58897746 | Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam |
| Q31016687 | Mass psychogenic illness following oral cholera immunization in Ca Mau City, Vietnam |
| Q35091828 | Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model. |
| Q33927450 | Meeting cholera's challenge to Haiti and the world: a joint statement on cholera prevention and care |
| Q43550972 | Modeling spatial heterogeneity of disease risk and evaluation of the impact of vaccination |
| Q30366933 | Molecular insights into the evolutionary pathway of Vibrio cholerae O1 atypical El Tor variants. |
| Q81487908 | Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA |
| Q91008239 | Multicountry Distribution and Characterization of Extended-spectrum β-Lactamase-associated Gram-negative Bacteria From Bloodstream Infections in Sub-Saharan Africa |
| Q40518745 | Multidisciplinary studies of disease burden in the Diseases of the Most Impoverished Programme. |
| Q64244519 | Multidrug-resistant Nontyphoidal Salmonella Hotspots as Targets for Vaccine Use in Management of Infections in Endemic Settings |
| Q30352675 | Multilocus sequence typing (MLST) analysis of Vibrio cholerae O1 El Tor isolates from Mozambique that harbour the classical CTX prophage. |
| Q37119279 | Multilocus sequence typing analysis of Shigella flexneri isolates collected in Asian countries |
| Q30386986 | Multilocus variable-number tandem repeat analysis of Vibrio cholerae O1 El Tor strains harbouring classical toxin B. |
| Q35167097 | Natural cholera infection-derived immunity in an endemic setting |
| Q24811352 | Neighborhood size and local geographic variation of health and social determinants |
| Q37880425 | New approaches to the assessment of vaccine herd protection in clinical trials |
| Q37953796 | New-generation vaccines against cholera |
| Q46653023 | Occurrence of shigellosis in the young and elderly in rural China: results of a 12-month population-based surveillance study. |
| Q91030324 | Oral cholera vaccination strategy: Self-administration of the second dose in urban Dhaka, Bangladesh |
| Q61791446 | Oral cholera vaccines to control endemic disease: an economic and epidemiological modelling analysis |
| Q82958075 | Oral cholera vaccines--a call for action |
| Q30401927 | Oral vaccines against cholera |
| Q64130108 | Organization and implementation of an oral cholera vaccination campaign in an endemic urban setting in Dhaka, Bangladesh |
| Q31035751 | Organizational aspects and implementation of data systems in large-scale epidemiological studies in less developed countries |
| Q30350881 | Pandemic serovars (O3:K6 and O4:K68) of Vibrio parahaemolyticus associated with diarrhea in Mozambique: spread of the pandemic into the African continent. |
| Q39941003 | Paperless registration during survey enumerations and large oral cholera mass vaccination in Zanzibar, the United Republic of Tanzania |
| Q53588316 | Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants. |
| Q61856728 | Phenotypic and genetic characterization of Vibrio cholerae O1 clinical isolates collected through national antimicrobial resistance surveillance network in Nepal |
| Q42186891 | Phenotypic and genotypic characteristics of Vibrio cholerae O1 isolated from the Sierra Leone cholera outbreak in 2012. |
| Q37702938 | Phenotypic profiles of enterotoxigenic Escherichia coli associated with early childhood diarrhea in rural Egypt |
| Q33613531 | Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide-diphtheria toxoid conjugates |
| Q33213069 | Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia |
| Q33194696 | Policymakers’ views on dengue fever/dengue haemorrhagic fever and the need for dengue vaccines in four southeast Asian countries |
| Q37744982 | Population impact of Vi capsular polysaccharide vaccine. |
| Q80840046 | Preferences for treatment of diarrhoea and dysentery in Kaengkhoi district, Saraburi province, Thailand |
| Q36635665 | Prevalence of Salmonella Excretion in Stool: A Community Survey in 2 Sites, Guinea-Bissau and Senegal |
| Q80600768 | Private demand for cholera vaccines in Hue, Vietnam |
| Q57929061 | Protecting children against Japanese encephalitis in Bali, Indonesia |
| Q98508243 | Protection conferred by typhoid fever against recurrent typhoid fever in urban Kolkata |
| Q40439364 | Putting typhoid vaccination on the global health agenda |
| Q92466352 | Randomization inference with general interference and censoring |
| Q40404190 | Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh |
| Q90686521 | Re-evaluating herd protection by Vi typhoid vaccine in a cluster randomized trial |
| Q51726589 | Relationship between neighbourhood-level killed oral cholera vaccine coverage and protective efficacy: evidence for herd immunity. |
| Q34165617 | Replacing paper data collection forms with electronic data entry in the field: findings from a study of community-acquired bloodstream infections in Pemba, Zanzibar |
| Q81434561 | Response to "questionable merits of the field trial of an oral killed whole cell cholera vaccine in Vietnam during 1998-2003" Vaccine 2007;25(8):1353-4 |
| Q36153627 | Retrospective Analysis of Serotype Switching of Vibrio cholerae O1 in a Cholera Endemic Region Shows It Is a Non-random Process |
| Q40435123 | Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings |
| Q39769526 | Risk factors for shigellosis in Thailand |
| Q34926521 | Risk map of cholera infection for vaccine deployment: the eastern Kolkata case. |
| Q39096112 | Role of phytoplankton in maintaining endemicity and seasonality of cholera in Bangladesh |
| Q42708834 | Rollback of Salmonella enterica serotype Typhi resistance to chloramphenicol and other antimicrobials in Kolkata, India |
| Q37261375 | Safe distances between groundwater-based water wells and pit latrines at different hydrogeological conditions in the Ganges Atrai floodplains of Bangladesh |
| Q54268700 | Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults. |
| Q39708963 | Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age. |
| Q64054143 | Safety of a bivalent, killed, whole-cell oral cholera vaccine in pregnant women in Bangladesh: evidence from a randomized placebo-controlled trial |
| Q37686863 | Safety of the oral cholera vaccine in pregnancy: Retrospective findings from a subgroup following mass vaccination campaign in Dhaka, Bangladesh |
| Q34359766 | Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy |
| Q33228201 | Salmonella paratyphi A rates, Asia |
| Q47178301 | Sample size determination for phase II studies of new vaccines |
| Q34119437 | Schools as potential vaccination venue for vaccines outside regular EPI schedule: results from a school census in Pakistan |
| Q39383873 | Serologic correlates of protection against enterotoxigenic Escherichia coli diarrhea |
| Q57925176 | Socioeconomic drivers of vaccine uptake: An analysis of the data of a geographically defined cluster randomized cholera vaccine trial in Bangladesh |
| Q38648231 | Socioeconomic risk factors for cholera in different transmission settings: An analysis of the data of a cluster randomized trial in Bangladesh |
| Q35945308 | Spatial risk for gender-specific adult mortality in an area of southern China |
| Q38150307 | Strategy, demand, management, and costs of an international cholera vaccine stockpile |
| Q34309550 | Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones |
| Q39645266 | Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine |
| Q53680563 | Suppressive effect of zinc on antibody response to cholera toxin in children given the killed, B subunit-whole cell, oral cholera vaccine |
| Q54493919 | Surveillance of pneumococcal-associated disease among hospitalized children in Khanh Hoa Province, Vietnam. |
| Q56942526 | Ten years of the Global Alliance for Vaccines and Immunization: challenges and progress |
| Q36412034 | The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study |
| Q36635676 | The Relationship Between Invasive Nontyphoidal Salmonella Disease, Other Bacterial Bloodstream Infections, and Malaria in Sub-Saharan Africa |
| Q38695279 | The STRATAA study protocol: a programme to assess the burden of enteric fever in Bangladesh, Malawi and Nepal using prospective population census, passive surveillance, serological studies and healthcare utilisation surveys |
| Q91008250 | The Severe Typhoid Fever in Africa Program: Study Design and Methodology to Assess Disease Severity, Host Immunity, and Carriage Associated With Invasive Salmonellosis |
| Q53175246 | The Supporting Independent Immunization and Vaccine Advisory Committees (SIVAC) initiative: a country-driven, multi-partner program to support evidence-based decision making. |
| Q98160150 | The Surveillance for Enteric Fever in Asia Project (SEAP), Severe Typhoid Fever Surveillance in Africa (SETA), Surveillance of Enteric Fever in India (SEFI), and Strategic Typhoid Alliance Across Africa and Asia (STRATAA) Population-based Enteric Fe |
| Q36635657 | The Typhoid Fever Surveillance in Africa Program (TSAP): Clinical, Diagnostic, and Epidemiological Methodologies |
| Q57275157 | The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26–27 October 2016, |
| Q24812819 | The burden of diarrhoea, shigellosis, and cholera in North Jakarta, Indonesia: findings from 24 months surveillance |
| Q34169960 | The burden of invasive bacterial infections in Pemba, Zanzibar |
| Q21144515 | The case for reactive mass oral cholera vaccinations |
| Q33373915 | The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries |
| Q97646486 | The epidemiology of dengue outbreaks in 2016 and 2017 in Ouagadougou, Burkina Faso |
| Q39775966 | The feasibility of a school-based VI polysaccharide vaccine mass immunization campaign in Hue City, central Vietnam: streamlining a typhoid fever preventive strategy |
| Q34637074 | The global burden of cholera. |
| Q21144553 | The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa |
| Q57291945 | The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis |
| Q36760789 | The introduction of new vaccines into developing countries. IV: Global Access Strategies |
| Q31031672 | The malaria and typhoid fever burden in the slums of Kolkata, India: data from a prospective community-based study |
| Q57932840 | The oral cholera vaccine Shanchol™ when stored at elevated temperatures maintains the safety and immunogenicity profile in Bangladeshi participants |
| Q59799133 | The phylogeography and incidence of multi-drug resistant typhoid fever in sub-Saharan Africa |
| Q33210204 | The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia. |
| Q37060884 | The use of a computerized database to monitor vaccine safety in Viet Nam. |
| Q40444791 | The use of typhoid vaccines in Asia: the DOMI experience |
| Q30777651 | The vaccine data link in Nha Trang, Vietnam: a progress report on the implementation of a database to detect adverse events related to vaccinations |
| Q40518750 | Translational research to assist policy decisions about introducing new vaccines in developing countries. |
| Q24647991 | Trend and disease burden of bacillary dysentery in China (1991-2000) |
| Q34092738 | Trends and disease burden of enteric fever in Guangxi province, China, 1994-2004 |
| Q40253950 | Trial participation and vaccine desirability for Vi polysaccharide typhoid fever vaccine in Hue City, Viet Nam. |
| Q34844912 | Typhoid fever in Fiji: a reversible plague? |
| Q37194768 | Typhoid vaccination: the Asian experience. |
| Q38456770 | Typhoid vaccine introduction: An evidence-based pilot implementation project in Nepal and Pakistan |
| Q64982832 | Unmasking herd protection by an oral cholera vaccine in a cluster-randomized trial. |
| Q96689995 | Use of Typhoid Vi-Polysaccharide Vaccine as a Vaccine Probe to Delineate Clinical Criteria for Typhoid Fever |
| Q49644672 | Use of oral cholera vaccine as a vaccine probe to define the geographical dimensions of person-to-person transmission of cholera |
| Q64095027 | Use of oral cholera vaccine as a vaccine probe to determine the burden of culture-negative cholera |
| Q33808779 | Use of oral cholera vaccines in an outbreak in Vietnam: a case control study. |
| Q34092762 | Use of verbal autopsy to determine mortality patterns in an urban slum in Kolkata, India. |
| Q43654784 | Using private demand studies to calculate socially optimal vaccine subsidies in developing countries |
| Q36522998 | Utilization and accessibility of healthcare on Pemba Island, Tanzania: implications for health outcomes and disease surveillance for typhoid fever |
| Q54268646 | Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission. |
| Q39958185 | Vaccine desirability during an effectiveness trial of the typhoid fever polysaccharide Vi vaccine in Kolkata India |
| Q53229873 | Vaccine introduction in the Democratic People's Republic of Korea. |
| Q40168559 | Validity of the estimates of oral cholera vaccine effectiveness derived from the test-negative design |
| Q38901161 | Variations of Invasive Salmonella Infections by Population Size in Asante Akim North Municipal, Ghana |
| Q30381317 | Vibrio cholerae Serogroup O139: Isolation from Cholera Patients and Asymptomatic Household Family Members in Bangladesh between 2013 and 2014. |
| Q33572955 | Vibriocidal antibody responses to a bivalent killed whole-cell oral cholera vaccine in a phase III trial in Kolkata, India |
| Q56340269 | What is the best immunization strategy for protecting African children against invasive Salmonella disease? |
| Q38176821 | When, how, and where can oral cholera vaccines be used to interrupt cholera outbreaks? |
| Q33222697 | Willingness to be vaccinated against shigella and other forms of dysentery: a comparison of three regions in Asia |
| John D. Clemens | wikipedia |
Search more.